Timothy Henry, MD, FACC

Dr. Timothy Henry, director of research at the Minneapolis Heart Institute Foundation, is an interventional cardiologist at the Minneapolis Heart Institute/Abbott Northwestern Hospital and Professor of Medicine at University of Minnesota School of Medicine.

Dr. Henry graduated from medical school at University of California, San Francisco, in 1982 and was chief medicine resident from 1982–1986 at University of Colorado Health Sciences Center. He completed his training as a cardiology fellow, chief cardiology fellow, and interventional cardiology fellow at University of Minnesota in 1991. His research interests include interventional cardiology, acute myocardial infarction, and novel therapies, including stem cell and gene therapy, for patients who are not candidates for standard revascularization techniques.

Dr. Henry has published over 300 manuscripts, book chapters, and abstracts and has served on the Research Committee for the Minnesota Affiliate of the AHA and the Emergency Care Committee for the ACC; he currently serves on the Advisory Committee for the AHA Mission: Lifeline Model Evaluation Task Force, the AHA Acute Cardiac Care Committee of the Council on Clinical Cardiology and on the ACC Interventional Subcommittee. He has served on steering committees of large, multicenter trials in ACS and angiogenesis, including TIMI-9, IN-TIME, TACTICS, VIVA, AGENT III, and several ongoing myocardial and peripheral angiogenesis trials. He is also principal investigator for 1 of 5 NIH Clinical Cardiovascular Stem Cell Centers. He is a fellow at ACC and SCAI and a member of Alpha Omega Alpha and the AHA Council on Clinical Cardiology.